A customer reported a false positive result with determine hiv 1/2 ag/ab combo.Sample information was not provided.Information further specifying the false positive result as antigen and/or antibody was not provided.Additional and/or confirmation testing was not provided.Attempts to gain further information were unsuccessful.Customer reported the patient was a double mastectomy cancer patient, and that the false positive result was expected, and not questioned.No further patient information, including pregnancy and art, was provided.There is insufficient information to determine if a malfunction occurred.Per the alere determine hiv-1/2 ag/ab combo product insert limitations: a reactive result using alere determine hiv-1/2 ag/ab combo suggests the presence of hiv-1 p24 antigen and/or antibodies to hiv-1 and/or hiv-2 in the sample.The reactive result is interpreted as preliminary positive for hiv-1 p24 antigen and/or antibodies to hiv-1 and/or hiv-2.Alere determine hiv-1/2 ag/ab combo is intended as aid in the diagnosis of infection with hiv-1/2.Specimens from individuals with toxoplasma igg, human anti-mouse antibodies, rheumatoid factor, elevated triglycerides (above 600 mg/dl), herpes simplex virus infection, hospitalized and cancer patients may give false positive test results.
|